Autoimmune And Rheumatic Diseases

SAN DIEGO — A clear intervention plan and collaboration with pulmonology are key to managing patients with interstitial lung disease in autoimmune conditions, according to a speaker at the Congress of Clinical Rheumatology West.

SAN DIEGO — The SARS-CoV-2 virus continues to evolve, sometimes on a daily basis, thus making consensus difficult to achieve in terms of how to continue fighting against COVID-19 and its ever-increasing sequelae, said a speaker here.

Patients with systemic autoimmune rheumatic diseases who developed COVID-19 during the first omicron wave were 71% less likely to experience severe outcomes than those who caught it in the first 4 months of the pandemic, according to data.

The Congress of Clinical Rheumatology-West will be held in a different venue in San Diego this year, but that should have no impact on the quality of the program.

The 2023 EULAR Congress of Rheumatology will commence as an exclusively in-person meeting, nixing the live remote option that has been in place since the start of the COVID-19 pandemic, the organization’s president announced.

Approximately 25% of immunocompromised patients have received a fifth vaccine dose, according to survey results released by the Global Healthy Living Foundation.

The word “gaslighting” has taken on a life of its own in recent years, being used in the context of interpersonal relationships, political discourse and online chatter alike.

This month’s roundtable, “Paradigms of distrust,” by a stellar cast of clinicians — Priya Fielding-Singh, PhD; Kenneth G. Saag, MD; Jen Sebring, BA(H), MSc; and Shilpa Venkatachalam, PhD, MPH — is a painful examination of moments in practice that are far from what we would envision as caring, and far from what we would want for ourselves or our loved ones if we were in need.

The apple doesn’t fall far from the tree. My dad was an orthopedist and my mom was an academic psychologist. If you cross those two, you get a rheumatologist.

ORLANDO — Altered gut flora has the potential to impact autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, noted a speaker at the 2022 Rheumatology Nurses Society Conference.